Key statistics
On Friday, Enanta Pharmaceuticals Inc (9EP:FRA) closed at 11.70, -17.61% below its 52-week high of 14.20, set on Dec 29, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.40 |
|---|---|
| High | 11.80 |
| Low | 11.40 |
| Bid | 11.60 |
| Offer | 11.80 |
| Previous close | 11.60 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 29.02m |
| Free float | 27.66m |
| P/E (TTM) | -- |
| Market cap | 401.92m USD |
| EPS (TTM) | -3.20 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 20:55 GMT.
More ▼
Press releases
- Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
- Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
- Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
